Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

RIoBORG Radiation-Induced Resistance in Triple-Negative Breast Cancer Organoids: Decoding the Role of Dose Fractionation and the Tumour Microenvironment in Precision Radiotherapy

Coordinator
Centre National De La Recherche Scientifique CNRS, France
Runs
1 September 2026 to 31 August 2028
Status
Running
EU funding
€226k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101271571

What the project is doing

In the project's own words, from its summary on CORDIS.

Radiotherapy fails in up to 40% of triple-negative breast cancer (TNBC) patients due to radioresistance mechanisms that remain poorly understood. RIoBORG (Radiation-Induced Resistance in Breast Cancer Organoids) addresses this urgent challenge using patient-derived xenograft organoids (PDXOs) as physiologically relevant models to study tumour-intrinsic and microenvironment-driven resistance. This translational project advances PDXO applications by integrating clinically relevant fractionated RT protocols with advanced tumour microenvironment (TME) modelling.

The study simulates clinical RT regimens under normoxic and hypoxic conditions to capture tumour heterogeneity. A novel 3D co-culture system combining PDXOs with stromal and endothelial cells will enable in-depth investigation of angiogenesis, inflammation, and hypoxia-induced radioresistance—key factors often overlooked in conventional models. A multi-modal strategy, encompassing functional assays, molecular phenotyping, and transcriptomic analysis, will facilitate the identification of radiosensitivity-associated signatures and predictive biomarkers in PDXOs.

Expected outputs include RT response profiles, biomarker panels, and stratification models that inform personalized treatment planning. The fellowship is strengthened by the host’s expertise in organoid and molecular profiling platforms and complemented by the fellow’s background in radiobiology, immunology, and bioinformatics. This synergy ensures interdisciplinary training aligned with MSCA goals and impactful research to improve personalized RT strategies in TNBC care.

Topics

Who is involved

OrganisationCityCountryRole
Centre National De La Recherche Scientifique CNRSParisFranceCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI